rs387907348
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001130004.2(ACTN1):c.137G>A(p.Arg46Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R46W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001130004.2 missense
Scores
Clinical Significance
Conservation
Publications
- platelet-type bleeding disorder 15Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- autosomal dominant macrothrombocytopeniaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460800Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726692 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Platelet-type bleeding disorder 15 Pathogenic:4
- -
- -
- -
This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 46 of the ACTN1 protein (p.Arg46Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with macrothrombocytopenia (PMID: 23434115, 24069336). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 42031). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ACTN1 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg46 amino acid residue in ACTN1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25361813). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Macrothrombocytopenia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at